Showing results (321-330 of 379) with videos related to
Sort By:
Pageof 38
Journal of the American College of Radiology : JACR|January 16, 2022
Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health AdministrationLucy B Spalluto, Jennifer A Lewis, Lauren R Samuels, et al.JTO Clinical and Research Reports|September 30, 2021
Clinical Characteristics and Molecular Profiles of Lung Cancer in EthiopiaTewodros H Gebremariam, Deborah A Haisch, Helen Fernandes, et al.Science Translational Medicine|April 9, 2010
Airway PI3K pathway activation is an early and reversible event in lung cancer developmentAdam M Gustafson, Raffaella Soldi, Christina Anderlind, et al.JNCI Cancer Spectrum|January 25, 2021
National Lung Cancer Screening Utilization Trends in the Veterans Health AdministrationJennifer A Lewis, Lauren R Samuels, Jason Denton, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 25, 2016
Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma MetastasisOlivier Boutaud, I Romina Sosa, Taneem Amin, et al.Transplantation Proceedings|December 21, 2010
Renal transplantation from living related donors: a single center experience in Viet NamH Ledinh, O Detry, M S Pham, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|February 22, 2021
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancerDaniel Ajona, Ana Remirez, Cristina Sainz, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
Predicting lung cancer prior to surgical resection in patients with lung nodulesStephen A Deppen, Jeffrey D Blume, Melinda C Aldrich, et al.Plos One|June 2, 2018
Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomasErica C Nakajima, Michael P Frankland, Tucker F Johnson, et al.Science Translational Medicine|January 11, 2023
Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancerKristin J Lastwika, Andrew Kunihiro, Joell L Solan, et al.Pageof 38